Leading in infusion and nutrition therapies
Pharmatel Fresenius Kabi Pty Ltd is one of Australia's fastest growing and innovative pharmaceutical companies, which is dedicated to improving the quality of life of patients in Australian hospitals by creating a new level of expertise and care.
Pharmatel Fresenius Kabi commenced operations on 1 September 2004 and is the result of a joint venture between a family owned Australian pharmaceutical company, Pharmatel, and a German-based multinational Fresenius Kabi.
Pharmatel Fresenius Kabi specialises in these key areas:
- Anaesthesia
- Blood Volume Substitution
- Critical Illness
- Fluid Management
- Gastroenterology
- Nutritional Support
- Oncology
The Company’s head office is located in Pymble NSW, in addition the company has two compounding facilities, located at Hornsby NSW and in West Melbourne, Victoria, along with a warehouse located in Silverwater NSW. The Company employs sales representatives in QLD, NSW, VIC, SA and WA covering all the Australian states and territories. Pharmatel Fresenius Kabi currently employs over 130 staff, with more positions planned with the growth expected in the future.
Pharmatel Fresenius Kabi is a subsidiary of the health care group Fresenius Kabi AG.
Fresenius Kabi AG is the leader in Infusion Therapy and Clinical Nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Fresenius Kabi are focused on the therapy and care of critically and chronically ill patients in and outside the hospital.
Fresenius Kabi has around 17,000 employees worldwide and a global network of 50 sales organizations and 45 production sites. We achieved sales of € 2,030 million and an operating profit of € 332 million in 2007.
Fresenius Kabi is a 100% subsidiary of the health care group Fresenius SE.
Key Figures
Fresenius Kabi: Sales Development
| €m | 2007 | 2006 | Organic Growth |
| Total Sales | 2,030 | 1,893 | 8 % |
| by Product Segment: |  | | |
| Infusion Therapy | 1,076 | 1,023 | 5 % |
| Clinical Nutrition | 831 | 753 | 12 % |
| Transfusion Technology | 123 | 117 | 5 % |
Fresenius Kabi: EBIT Development
| €m | 2007 | 2006 | Change |
| EBIT | 332 | 291 | 14% |
| EBIT margin | 16.4 % | 15.4 % | |
| EBIT by Region: | | | |
| Europe | 294 | 256 | 15 % |
| EBIT margin | 21.6% | 19.6% | |
| International | 113 | 100 | 13 % |
| EBIT margin | 17.0 % | 17.0% | |
| Corporate / Corporate R&D | - 75 | - 65 | |
Interlinked Product Portfolio
Pharmatel Fresenius Kabi's interlinked product portfolio ensures a high quality, comprehensive product range from one source.
Infusion Therapy
Our product range includes infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems.
Infusion therapy products are essential medications, which are mainly used in surgery, intensive and emergency medicine and on general wards.
Clinical Nutrition
Pharmatel Fresenius Kabi offers infusion solutions for parenteral nutrition (nutrition via the vein). Clinical nutrition products are required during a stay in the hospital as well as in the ambulatory environment.
Parenteral nutrition avoids the gastro-intestinal tract
Parenteral nutrition is administered intravenously to help patients who cannot eat any, or sufficient, normal food. This is especially the case for patients in intensive care units, for patients who are seriously ill and with malnutrition. When the patient leaves the hospital the ambulatory services of Pharmatel Fresenius Kabi can care for the patient and provide them with the necessary products.
Gastroenterology
Our gastroenterology range comprises bowel preparation products for use prior to gastrointestinal examination or surgery and a treatment for ulcerative colitis.
Oncology and Parenteral Nutrition Compounding
Pharmatel Fresenius Kabi has two TGA registered aseptic compounding facilities, preparing tailor-made chemotherapy and parenteral nutrition for cancer and critically-ill patients in Australian hospitals. The specialised sterile facilities assure product reliability and safety.
Thank you for visiting our website www.pfk.com.au . For further questions please send us an email at info@pfk.com.au
Pharmatel Fresenius Kabi, Pty Ltd.
Locked Bag 1074
Pymble
NSW 2073
Australia
Tel.: +61 2 9391 5555